Showing results (21-30 of 29) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Journal of Vascular and Interventional Radiology : JVIR|April 20, 2020
Gallbladder Cryoablation for Chronic Cholecystitis in High-Risk Surgical Patients: 1-Year Clinical Experience with Imaging Follow-upHugh McGregor, Gregory Woodhead, Mikin Patel, et al.The American Journal of Hospice & Palliative Care|April 18, 2026
Evaluation of CT-Guided Pudendal Nerve Cryoneurolysis for the Treatment of Refractory Pelvic PainShamar Young, Ahmet Gunkan, Lucas Struycken, et al.The American Journal of Hospice & Palliative Care|November 7, 2025
Comparison of Outcomes in Splanchnic Nerve and Celiac Plexus Cryoneurolysis for the Treatment of Refractory Abdominal PainDaniel Goldberg, Zachary Fitzgerald, Alan Sag, et al.Cardiovascular and Interventional Radiology|July 29, 2026
Evaluating the Predictive Value of Pre-procedural Diagnostic Nerve Blocks in Patients Undergoing CryoneurolysisShamar Young, Ahmet Gunkan, Sarah Placek, et al.Expert Opinion on Investigational Drugs|December 16, 2021
Tilsotolimod: an investigational synthetic toll-like receptor 9 (TLR9) agonist for the treatment of refractory solid tumors and melanomaChristian Karime, Jing Wang, Gregory Woodhead, et al.Cardiovascular and Interventional Radiology|September 21, 2025
Percutaneous Sclerotherapy Versus Transarterial Chemoembolization for Giant Hepatic Hemangiomas: A Systematic Review and Meta-analysisAlperen Elek, Ahmet Günkan, Victor Arthur Ohannesian, et al.Diagnostics (Basel, Switzerland)|January 10, 2026
Understanding Current Trends and Advances in Transarterial Radioembolization DosimetryShamar Young, Kiyon Naser-Tavakolian, Abin Sajan, et al.Journal of Vascular and Interventional Radiology : JVIR|July 9, 2025
Safety and Effectiveness of Image-Guided Therapies for Giant Hepatic Hemangiomas: A Systematic Review and Meta-Analysis of 2,617 PatientsAhmet Günkan, Alperen Elek, Victor Arthur Ohannesian, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 2, 2022
Tilsotolimod Exploits the TLR9 Pathway to Promote Antigen Presentation and Type 1 IFN Signaling in Solid Tumors: A Multicenter International Phase I/II Trial (ILLUMINATE-101)Hani Babiker, Erkut Borazanci, Vivek Subbiah, et al.Pageof 3